Jiwa Bio-Pharm Holdings Limited has sold a majority stake to U-Home Group International Ltd.
U-Home Group International Litd. has acquired 72.19% of the issued share capital in Jiwa Bio-Pharm Holdings Limited, for a consideration of US$35.9 million.
The company trades in pharmaceutical and healthcare products, research and development of chemical and biological products, and investment and treasury functions.
U-Home Group International Ltd. is a company owned by Yuhua Enterprises Co Ltd.
Oaklins' team in Hong Kong acted as financial advisor to Jiwa Bio-Pharm Holdings Limited regarding this transaction.
Talk to the deal team
Related deals
Garden care product manufacturer Doff Portland has been acquired by Pelsis Group
Global pest control manufacturer and supplier Pelsis Group has added Doff Portland to its product portfolio. Doff Portland becomes a wholly owned subsidiary within the group.
Learn moreUniKidz has partnered with Karmijn Kapitaal
Karmijn Kapitaal has acquired a majority stake in UniKidz, a talent development organization that provides a scientifically-based developmental approach through high-quality childcare. Through the partnership with Karmijn Kapitaal, UniKidz can take the next step in bringing their unique concept to even more children.
Learn moreProvital GmbH has been acquired by EMERAM Capital Partners
Dr. Thomas Brandner has sold a majority stake in Provital GmbH to private equity firm EMERAM Capital Partners. The transaction secures the future development and growth opportunities of the pet food company as EMERAM Capital Partners takes on ownership and acts as its strategic partner.
Learn more